Featured Research

from universities, journals, and other organizations

OHSU Researchers Discover Breast Cancer Gene Inhibitor

Date:
September 15, 1999
Source:
Oregon Health Sciences University
Summary:
Researchers at Oregon Health Sciences University and the Vollum Institute have discovered a naturally occurring protein that inhibits the functions of the HER-2 oncogene, a major factor in breast and other cancers.

After Years of Study, Protein is Found that Blocks Activity of HER-2 Gene

Related Articles


Portland, Ore. - Researchers at Oregon Health Sciences University and the Vollum Institute have discovered a naturally occurring protein that inhibits the functions of the HER-2 oncogene, a major factor in breast and other cancers. The protein, dubbed herstatin, blocks the HER-2 signaling activity that causes tumor cells to grow, ultimately killing those cells. The findings are reported in the September issue of Proceedings of the National Academy of Sciences.

"This particular gene, HER-2, has such a clear-cut role in breast cancer that if you can inhibit its biochemical activity, you should be able to control the cancer," said Gail Clinton, Ph.D., associate professor of biochemistry and molecular biology at OHSU's School of Medicine.

Clinton and her former student, Joni Doherty, M.D., Ph.D., discovered herstatin while investigating the reasons why HER-2 acts so aggressively in tumor development. An overabundance of HER-2 is present in 25 to 30 percent of breast cancer cases and results in significantly lower survival rates and shorter time to relapse. Besides breast cancer, HER-2 is strongly linked to ovarian, gastric, endometrial and salivary gland cancers and possibly to prostate and colon cancers.

Although the HER-2 oncogene was discovered nearly 20 years ago, and has been studied intensely by scientists around the world, herstatin is the first naturally occurring molecule found to inhibit HER-2. During their research, Clinton and Doherty uncovered a novel mechanism for generation of a HER-2 binding protein resulting in the discovery of herstatin. Because their work involved human cells in culture, there is promise that the protein can be developed into a treatment.

"It's a long way from cells in culture to treating patients, but we are very optimistic about our findings," Clinton said. In addition to Doherty, who is now a surgical fellow at the University of Southern California, other researchers involved were John Adelman, Ph.D., and Chris Bond, M.S., of the Vollum Institute and Armando Jardim, Ph.D., of OHSU.


Story Source:

The above story is based on materials provided by Oregon Health Sciences University. Note: Materials may be edited for content and length.


Cite This Page:

Oregon Health Sciences University. "OHSU Researchers Discover Breast Cancer Gene Inhibitor." ScienceDaily. ScienceDaily, 15 September 1999. <www.sciencedaily.com/releases/1999/09/990915080618.htm>.
Oregon Health Sciences University. (1999, September 15). OHSU Researchers Discover Breast Cancer Gene Inhibitor. ScienceDaily. Retrieved November 28, 2014 from www.sciencedaily.com/releases/1999/09/990915080618.htm
Oregon Health Sciences University. "OHSU Researchers Discover Breast Cancer Gene Inhibitor." ScienceDaily. www.sciencedaily.com/releases/1999/09/990915080618.htm (accessed November 28, 2014).

Share This


More From ScienceDaily



More Health & Medicine News

Friday, November 28, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Ebola Leaves Orphans Alone in Sierra Leone

Ebola Leaves Orphans Alone in Sierra Leone

AFP (Nov. 27, 2014) — The Ebola epidemic sweeping Sierra Leone is having a profound effect on the country's children, many of whom have been left without any family members to support them. Duration: 01:02 Video provided by AFP
Powered by NewsLook.com
Experimental Ebola Vaccine Shows Promise In Human Trial

Experimental Ebola Vaccine Shows Promise In Human Trial

Newsy (Nov. 27, 2014) — A recent test of a prototype Ebola vaccine generated an immune response to the disease in subjects. Video provided by Newsy
Powered by NewsLook.com
Pet Dogs to Be Used in Anti-Ageing Trial

Pet Dogs to Be Used in Anti-Ageing Trial

Reuters - Innovations Video Online (Nov. 26, 2014) — Researchers in the United States are preparing to discover whether a drug commonly used in human organ transplants can extend the lifespan and health quality of pet dogs. Video provided by Reuters
Powered by NewsLook.com
Today's Prostheses Are More Capable Than Ever

Today's Prostheses Are More Capable Than Ever

Newsy (Nov. 26, 2014) — Advances in prosthetics are making replacement body parts stronger and more lifelike than they’ve ever been. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:

Strange & Offbeat Stories

 

Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins